Literature DB >> 27838830

Prevalence of clinically relevant muscle weakness and its association with vitamin D status among older adults in Ecuador.

Carlos H Orces1.   

Abstract

BACKGROUND: Muscle weakness and 25-hydroxyvitamin D (25(OH)D) deficiency have been associated with adverse outcomes among older adults. However, little is known about the relationship between clinically relevant muscle weakness and 25(OH)D levels in Ecuador. AIMS: To examine the prevalence of muscle weakness and its association with 25(OH)D status among subjects aged 60 years and older in Ecuador.
METHODS: The present study was based on data from 2205 participants in the first National Survey of Health, Wellbeing, and Aging. The Foundation for the National Institute of Health Sarcopenia Project criteria was used to examine muscle weakness prevalence rates. Gender-specific general linear and logistic regression models adjusted for potential confounders were created to compare mean 25(OH)D concentrations and 25(OH)D deficiency across muscle strength categories, respectively.
RESULTS: An estimated 32.2% of women and 33.4% of men had evidence of clinically relevant muscle weakness in Ecuador. In general, increased muscle weakness prevalence rates were present among Indigenous, residents in the rural Andes Mountains, underweight subjects, and those with a sedentary lifestyle. Muscle strength was significantly and directly correlated with mean 25(OH)D levels. After controlling for potential confounders, 25(OH)D deficiency prevalence rates were 31 and 43% higher among men and women with muscle weakness than those with normal strength, respectively.
CONCLUSIONS: One-third of older adults nationwide had evidence of muscle weakness. While the present study found a significant correlation between muscle strength and 25(OH)D concentrations, further research is needed to examine whether optimizing 25(OH)D levels may improve muscle weakness among older adults.

Entities:  

Keywords:  Ecuador; Grip strength; Older adults; Vitamin D; Weakness

Mesh:

Substances:

Year:  2016        PMID: 27838830     DOI: 10.1007/s40520-016-0678-3

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  6 in total

Review 1.  Prevalence of vitamin D insufficiency and evidence for disease prevention in the older population.

Authors:  Julia Kühn; Paula Trotz; Gabriele I Stangl
Journal:  Z Gerontol Geriatr       Date:  2018-04-17       Impact factor: 1.281

2.  The associations between serum 25-hydroxyvitamin D level and the risk of total fracture and hip fracture.

Authors:  Y Feng; G Cheng; H Wang; B Chen
Journal:  Osteoporos Int       Date:  2017-02-20       Impact factor: 4.507

3.  Are Serum 25-Hydroxyvitamin D Deficiency and Insufficiency Risk Factors for the Incidence of Dynapenia?

Authors:  Maicon Luís Bicigo Delinocente; Mariane Marques Luiz; Dayane Capra de Oliveira; Aline Fernanda de Souza; Paula Camila Ramírez; Roberta de Oliveira Máximo; Natália Cochar Soares; Andrew Steptoe; Cesar de Oliveira; Tiago da Silva Alexandre
Journal:  Calcif Tissue Int       Date:  2022-09-15       Impact factor: 4.000

4.  Prevalence of motor impairment in residents of New South Wales, Australia aged 55 years and over: cross-sectional survey of the 45 and Up cohort.

Authors:  R D Herbert; J L Taylor; S R Lord; S C Gandevia
Journal:  BMC Public Health       Date:  2020-09-04       Impact factor: 3.295

5.  Analysis of Related Factors of Brittle Hip Fracture in Postmenopausal Women with Osteoporosis.

Authors:  Hua-Feng Zhuang; Pei-Wen Wang; Yi-Zhong Li; Jin-Kuang Lin; Xue-Dong Yao; Hao Xu
Journal:  Orthop Surg       Date:  2020-01-13       Impact factor: 2.071

6.  The Association between 25-Hydroxyvitamin D Concentration and Disability Trajectories in Very Old Adults: The Newcastle 85+ Study.

Authors:  Sarah Hakeem; Nuno Mendonca; Terry Aspray; Andrew Kingston; Carmen Ruiz-Martin; Carol Jagger; John C Mathers; Rachel Duncan; Tom R Hill
Journal:  Nutrients       Date:  2020-09-09       Impact factor: 6.706

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.